InvestorsHub Logo
Followers 253
Posts 6621
Boards Moderated 1
Alias Born 06/13/2013

Re: stervc post# 61789

Friday, 04/10/2020 7:09:13 PM

Friday, April 10, 2020 7:09:13 PM

Post# of 73640
Stervc, I believe I have uncovered some SIGNIFICANT DD with BIEI.....

In my research I have uncovered some information with UTEP - University of Texas El Paso, with whom BIEI is partnered with......

As you can see, this partnership has been documented for several years and can also be seen on the company's website....

"About Premier Biomedical, Inc.

Premier Biomedical, Inc. (OTCQB:BIEI) is a research-based publicly traded company that intends to discover and develop medical treatments for a wide range of diseases in humans. Premier has obtained, via exclusive license agreements, the technology behind three granted US Patents, multiple pending provisional patents. Founded in 2010, Premier has partnered with the University of Texas at El Paso (UTEP). In 2016, the company began developing a line of all-natural pain relief products which they began selling in early 2017 to address the rising opioid addiction problem. The company's R&D efforts are centered in El Paso, TX, and their business offices are in Western Pennsylvania. "

Notice the Research & Development for BIEI product(s) takes place in El Paso, TX. This, in my opinion, can most likely mean to suggest that the company R&D efforts are done with the University partner at their facilities.

Now, notice the HINT dropped by the company in Monday's PR (4-6-2020)

"Dr. Mitchell Felder, Chairman of the Board of Premier Biomedical, Inc., stated, "Premier's realignment will secure necessary funds to continue research with our university partner to develop the provisional patent application entitled "Method for Treating and Curing COVID-19 Infection," as noted in our prior announcement of March 23, 2020."
https://www.otcmarkets.com/stock/BIEI/news/Premier-Biomedical-Realigns-Business-to-Eliminate-Convertible-Debt-Cancel-Reverse-Split--Fund-Covid-19-RD?id=258461


Now, here's the piece I find interesting...... Don't get me wrong there's a lot of reading between the lines at this point, but if it fills in as im speculating it may, this could be Huge imo.......

From UTEP Communications published on Wednesday, 4-8-2020,
"UTEP School of Pharmacy Developing COVID-19 Vaccine, Drug Treatments Using Supercomputing...
uman Sirimulla, Ph.D., assistant professor of pharmaceutical sciences at UTEP, is leading a group of experimental researchers to virtually develop the molecular structure of a protease inhibitor that would target the coronavirus, which causes COVID-19, a respiratory illness that can spread from person to person.

“UTEP faculty members advance discovery of public value,” said UTEP President Heather Wilson. “We have high expectations for Dr. Sirimulla’s research and look forward to his development of therapies to combat the novel coronavirus infection.”

Sirimulla is collaborating with UTEP faculty members Md Nurunnabi, Ph.D., assistant professor of pharmaceutical sciences, and Manuel Llano M.D., Ph.D., associate professor in the Department of Biological Sciences; and Tudor I. Oprea, professor of medicine and chief, Translational Informatics Division, Department of Internal Medicine at the University of New Mexico.

Using computational methods, Sirimulla is piecing together small molecules to create inhibitors of viral proteins – specifically, inhibitors that will bind to the coronavirus’s S-protein, or spike protein, and block it from attaching to and infecting healthy cells. He is also developing inhibitors of coronavirus main protease, which is an attractive target due to its essential role in processing the polyproteins that are translated from the viral RNA. Scientists will be able to use the new protease inhibitor to develop drugs effective against COVID-19."
https://www.utep.edu/newsfeed/campus/utep-school-of-pharmacy-develops-covid-19-vaccine-drug-treatments-using-supercomputing.html

It goes on to say more but I will leave it at that...... Now, notice the article says they are developing a VACCINE. Also notice in the bolded it states, "inhibitors that will bind to the coronavirus’s S-protein..."

Now, lets see what BIEI 3/23/2020 PR says, "The patent application involves the removal of disease-specific antigens via an extracorporeal process. These antigens are associated with the ability of Covid-19 to replicate. By targeting these disease antigens with a complexing agent and causing them to bind together, the resulting molecular compound can then be removed in a brief clinical process." AND..... "We have already received verbal agreement from a major university partner that they would be able to produce the necessary specific antibodies in a relatively short period of time...". ONE MORE THING.... "We believe that these antibodies may also be utilized as an intravenous drug therapy for Covid-19 patients in addition to their use in our extracorporeal treatment process."
INTRAVENOUS..... maybe like a vaccine? Bind to the protein? ..... Maybe like the patent of BIEI's??
We already know they are longstanding partners and the PR acknowledges they have a verbal agreement from a "major university partner"........

From UTEP: "We have high expectations for Dr. Sirimulla’s research and look forward to his development of therapies to combat the novel coronavirus infection.” Now notice what BIEI stated.... "We believe that these antibodies may also be utilized as an intravenous drug therapy..." Coincidence? You decide....
https://www.otcmarkets.com/stock/BIEI/news/Covid-19-Treatment-Provisional-Patent-Application-Filed-Premier-Biomedical-Inc-Granted-Global-Commercial-Rights?id=257204

From the information I see, I believe its quite clear that something major is going on. The company certainly seems to believe so too in my opinion with the CANCELLATION OF THE REVERSE SPLIT on Monday, the announcement of their plans this week to eliminate the notes, and the recent insider buying as can be seen in the Form 4's...... If they can eliminate these notes/debts and execute with their verbal agreements with a university partner which I believe is UTEP, then this could be one for the record books..... In the end its all about the company executing properly and by the looks of it with the recent positive press releases, I do believe they are trying......


For the record to any readers of this, this is just my personal DD..... this is not investment advice nor am I certain of the accuracy of the opinions and information listed.... Always do your own research.....